Author:
Warnken Zachary,Lu Yang,Smyth Hugh D. C.,Williams Robert O.
Reference89 articles.
1. Pardridge WM (2005) The blood-brain barrier: bottleneck in brain drug development. NeuroRx 2(1):3–14
2. Alzheimer’s Association (2016) 2016 Alzheimer’s disease facts and figures. Alzheimers Dement 12(4):459–509
3. DiMasi JA, Feldman L, Seckler A, Wilson A (2010) Trends in risks associated with new drug development: success rates for investigational drugs. Clin Pharmacol Ther 87(3):272–277. https://doi.org/10.1038/clpt.2009.295
4. Warnken ZN, Smyth HDC, Watts AB, Weitman S, Kuhn JG, Williams Iii RO (2016) Formulation and device design to increase nose to brain drug delivery. J Drug Deliv Sci Technol 35:213–222. https://doi.org/10.1016/j.jddst.2016.05.003
5. Lockhead J, Thorne RG (2013) Intranasal drug delivery to the brain. In: Hammarlund-Udenaes M, Thorne RG (eds) Drug delivery to the brain: physiological concepts, methodologies and approaches. Springer Science & Business Media, New York, NY